Francisco Rodriguez Pulido
San Cristóbal de La Laguna, Santa CRUZ DE Tenerife, 38205, Spain
NCT Number: NCT05866328
Randomized controlled trial. Sixty-five participants (83% with schizophrenia or bipolar disorder) were recruited from community mental health teams. Fifty-seven met criteria and agreed to participate in the study. The conditions of cognitive rehabilitation were assigned randomly with support employment CR + IPS (n = 28) and IPS alone (n = 29). Cogpack program was used. Two groups were followed at 8 and 12 months after the baseline.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
San Cristóbal de La Laguna, Santa CRUZ DE Tenerife, 38205, Spain
This work was developed in the island of Tenerife (Spain) within a public service specialised in labour integration of people with disabilities in which an IPS team was set up in 2005. The study was carried out in collaboration with the units of community mental health of the island. These units carry out the control of people with serious mental illnesses including pharmacological treatment and psychosocial programming. All research procedures were approved by the Medicine Committee of Canary Health Services.
The follow-up period for the data collection was set between 2013 and 2014. Employment specialists belong to a public institution specialized in work disability.Sixty-five participants but only 57 signed written informed consent and completed the baseline. Two groups were assigned randomly:one with support employment and cognitive rehabilitation the second group with IPS alone
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participants had to:
Exclusion criteria
People with no Severe mental illness and not want to participate
Cognitive Rehabilitation and Individual Placement and Support
Other names: CR and IPS
Time frame: At baseline and after 1 year treatment
Minimum 0 and maximum 60. Between 20-40 years average 51.43, cut-off point 45, below deficit. Between 40-60 years, average 51.20, cut-off point 43, below deficit.
Time frame: At baseline and after 1 year treatment
Total 1 minimum 0 and maximum 20. Total 2 minimum 0 and maximum 10. Cut-off point 18, less deficit.
Time frame: At baseline and after 1 year treatment
Total control minimum 0 and maximum 16. Total theory of mind minimum 0 and maximum 16. Cut-off point 14, below the deficit.
Time frame: At baseline and after 1 year treatment
FP stories and C questions, C stories and FP questions and C stories and C questions minimum 0 and maximum 20. FP stories and FP questions minimum 0 and maximum 60. Cut-off point without errors 54 and with errors 48, lower deficit scores.
Time frame: At baseline and after 1 year treatment
Hostility, anger, guilt and aggression minimum 1 and maximum 5. Intentionality minimum 1 and maximum 6. Calculate the mean.
Time frame: At baseline and after 1 year treatment
Minimum 0 and maximum 42.
Time frame: At baseline and after 1 year treatment
Minimum 1 and maximum 99, very low range 1-2.5 and low range 2.5-15. The deterioration depends on the scale.
Time frame: At baseline and after 1 year treatment
Positive and negative subscales minimum 7 and maximum 49. General psychopathology subscale minimum 16 and maximum 112. Composite subscale minimum -42 and maximum +42. Categorize subtype positive >0 and negative <0.
Time frame: Up to 12 months in 2021
Number of jobs
University of La Laguna
Other
Online Training Program on Social Cognition for Patients With Schizophrenia
Acronym: TP;SC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02567032
Mental Disorders, Oxytocin
San Francisco, California, United States
View Trial DetailsNCT00884897
Emotional Intelligence, Mental Disorders
Catonsville, Maryland, United States
View Trial DetailsNCT02568709
Magnetoencephalography (MEG), Mental Disorders
San Francisco, California, United States
View Trial DetailsNCT02566356
Functional Magnetic Resonance Imaging (fMRI), Mental Disorders
San Francisco, California, United States
View Trial Details